within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A02B_DrugsForPepticUlcerAndGastroOesophagealRefluxDiseaseGord.A02BC08_Vonoprazan;
model Vonoprazan 
   extends Pharmacolibrary.Drugs.ATC.A.A02BC08;

  annotation(Documentation(
    info ="<html><body><p>Vonoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related diseases such as gastroesophageal reflux disease (GERD) and peptic ulcer. It is approved and used in various countries for gastric acid suppression.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after single oral administration.</p><h4>References</h4><ol><li><p>Echizen, H (2016). The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations. <i>Clinical pharmacokinetics</i> 55(4) 409–418. DOI:<a href=&quot;https://doi.org/10.1007/s40262-015-0326-7&quot;>10.1007/s40262-015-0326-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26369775/&quot;>https://pubmed.ncbi.nlm.nih.gov/26369775</a></p></li><li><p>Shen, J, et al., &amp; Liu, B (2020). Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats. <i>Drug design, development and therapy</i> 14 2199–2206. DOI:<a href=&quot;https://doi.org/10.2147/DDDT.S255427&quot;>10.2147/DDDT.S255427</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32581516/&quot;>https://pubmed.ncbi.nlm.nih.gov/32581516</a></p></li><li><p>Kong, WM, et al., &amp; Liu, XD (2020). Physiologically based pharmacokinetic-pharmacodynamic modeling for prediction of vonoprazan pharmacokinetics and its inhibition on gastric acid secretion following intravenous/oral administration to rats, dogs and humans. <i>Acta pharmacologica Sinica</i> 41(6) 852–865. DOI:<a href=&quot;https://doi.org/10.1038/s41401-019-0353-2&quot;>10.1038/s41401-019-0353-2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31969689/&quot;>https://pubmed.ncbi.nlm.nih.gov/31969689</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Vonoprazan;
